Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Hold” by Brokerages

Shares of Masimo Corporation (NASDAQ:MASI) have been assigned an average recommendation of “Hold” from the nine ratings firms that are currently covering the company, MarketBeat reports. Nine research analysts have rated the stock with a hold rating. The average twelve-month price objective among brokers that have covered the stock in the last year is $180.40.

MASI has been the topic of a number of recent research reports. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th.

Institutional Trading of Masimo

Large investors have recently modified their holdings of the stock. Massachusetts Financial Services Co. MA increased its holdings in Masimo by 1.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after buying an additional 43,915 shares during the period. T. Rowe Price Investment Management Inc. boosted its position in shares of Masimo by 9.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock worth $303,061,000 after acquiring an additional 203,395 shares in the last quarter. Naya Capital Management UK Ltd. acquired a new stake in shares of Masimo during the 4th quarter worth approximately $202,984,000. Westfield Capital Management Co. LP increased its stake in Masimo by 7.2% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after acquiring an additional 102,799 shares during the last quarter. Finally, State Street Corp raised its position in Masimo by 0.7% during the second quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after purchasing an additional 10,403 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Performance

MASI stock remained flat at $179.95 during trading hours on Friday. Masimo has a 1-year low of $125.94 and a 1-year high of $179.99. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $9.42 billion, a PE ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. The company’s fifty day moving average is $179.28 and its 200-day moving average is $166.08.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.